For more information on WoundExpert, visit nethealth.com/See-WoundExpert.About Net Health Net Health is the leader in software solutions for specialized outpatient care. Known for being experts in The Art of the Right Fit®, fully interoperable EHR solutions serve five medical specialty markets. Offering clients an end-to-end solution that includes practice management tools, clinical workflow documentation, revenue cycle management, and analytics, Net Health serves healthcare professionals in 3,700 urgent care, wound care, physical therapy, speech and language therapy, occupational therapy, occupational medicine, employee health, and workplace medicine facilities. Net Health is committed to strengthening patient care, outcomes, and facility performance. Learn more at nhsinc.com. Net Health is a Spectrum Equity portfolio company. About Osiris Therapeutics Osiris Therapeutics, Inc., based in Columbia, Maryland, is a world leader in researching, developing and marketing regenerative medicine products that improve health and lives of patients and lower overall healthcare costs. Having developed the world's first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine - including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4®, Cartiform®, Grafix®, TruSkin TM and Stravix TM. Osiris, Grafix, Cartiform, TruSkin, and Stravix are trademarks of Osiris Therapeutics, Inc. BIO4® is a trademark of Howmedica Osteonics Corp. More information can be found on the company's website, www.Osiris.com. (OSIR-G). Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as "anticipate," "believe," "continue," "ongoing," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project" or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Examples of forward-looking statements may include, without limitation, statements regarding the anticipated efficiencies and advantages of new services and the likelihood of customer adoption of new services. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Accordingly, you should not unduly rely on these forward-looking statements. We undertake no obligation to publicly revise any forward-looking statement to reflect circumstances or events after the date of this press release or to reflect the occurrence of unanticipated events.
For additional information, please contact:Diane SavoieOsiris Therapeutics, Inc.(443) 545-1834 OsirisPR@Osiris.com